These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20877351)

  • 1. Human Th17 cells can be induced through head and neck cancer and have a functional impact on HNSCC development.
    Kesselring R; Thiel A; Pries R; Trenkle T; Wollenberg B
    Br J Cancer; 2010 Oct; 103(8):1245-54. PubMed ID: 20877351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokines in head and neck cancer.
    Pries R; Wollenberg B
    Cytokine Growth Factor Rev; 2006 Jun; 17(3):141-6. PubMed ID: 16540364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4/CCL22 in head and neck squamous cell carcinoma.
    Tsujikawa T; Yaguchi T; Ohmura G; Ohta S; Kobayashi A; Kawamura N; Fujita T; Nakano H; Shimada T; Takahashi T; Nakao R; Yanagisawa A; Hisa Y; Kawakami Y
    Int J Cancer; 2013 Jun; 132(12):2755-66. PubMed ID: 23180648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complement receptors CD46, CD55 and CD59 are regulated by the tumour microenvironment of head and neck cancer to facilitate escape of complement attack.
    Kesselring R; Thiel A; Pries R; Fichtner-Feigl S; Brunner S; Seidel P; Bruchhage KL; Wollenberg B
    Eur J Cancer; 2014 Aug; 50(12):2152-61. PubMed ID: 24915776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory role of bitter melon extract in inhibition of head and neck squamous cell carcinoma growth.
    Bhattacharya S; Muhammad N; Steele R; Peng G; Ray RB
    Oncotarget; 2016 May; 7(22):33202-9. PubMed ID: 27120805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the evolution of immune phenotype during the development and progression of squamous cell carcinoma of the head and neck.
    De Costa AM; Schuyler CA; Walker DD; Young MR
    Cancer Immunol Immunother; 2012 Jun; 61(6):927-39. PubMed ID: 22116344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment to sustain a Th17-type phenotype to prevent skewing toward Treg and to limit premalignant lesion progression to cancer.
    Young MR; Levingston CA; Johnson SD
    Int J Cancer; 2016 May; 138(10):2487-98. PubMed ID: 26756968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor microenvironments direct the recruitment and expansion of human Th17 cells.
    Su X; Ye J; Hsueh EC; Zhang Y; Hoft DF; Peng G
    J Immunol; 2010 Feb; 184(3):1630-41. PubMed ID: 20026736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The number of CD161 positive Th17 cells are decreased in head and neck cancer patients.
    Kesselring R; Thiel A; Pries R; Wollenberg B
    Cell Immunol; 2011; 269(2):74-7. PubMed ID: 21570678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer.
    Jebreel A; Mistry D; Loke D; Dunn G; Hough V; Oliver K; Stafford N; Greenman J
    J Laryngol Otol; 2007 Mar; 121(3):246-52. PubMed ID: 17040593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphotoxin-α promotes tumor angiogenesis in HNSCC by modulating glycolysis in a PFKFB3-dependent manner.
    Yang JG; Wang WM; Xia HF; Yu ZL; Li HM; Ren JG; Chen G; Wang BK; Jia J; Zhang W; Zhao YF
    Int J Cancer; 2019 Sep; 145(5):1358-1370. PubMed ID: 30785217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in head and neck cancers.
    Uppaluri R; Dunn GP; Lewis JS
    Cancer Immun; 2008 Dec; 8():16. PubMed ID: 19053167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific blockade CD73 alters the "exhausted" phenotype of T cells in head and neck squamous cell carcinoma.
    Deng WW; Li YC; Ma SR; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
    Int J Cancer; 2018 Sep; 143(6):1494-1504. PubMed ID: 29663369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of adenosine A2A receptor enhances CD8
    Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
    Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive T-cell immunophenotyping and next-generation sequencing of human papillomavirus (HPV)-positive and HPV-negative head and neck squamous cell carcinomas.
    Poropatich K; Fontanarosa J; Swaminathan S; Dittmann D; Chen S; Samant S; Zhang B
    J Pathol; 2017 Nov; 243(3):354-365. PubMed ID: 28771750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell surface markers for T and B lymphocytes activation and adhesion as putative prognostic biomarkers for head and neck squamous cell carcinoma.
    Andrade MC; Ferreira SB; Gonçalves LC; De-Paula AM; de Faria ES; Teixeira-Carvalho A; Martins-Filho OA
    Hum Immunol; 2013 Dec; 74(12):1563-74. PubMed ID: 23994583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulation in immune functions is reflected in tumor cell cytotoxicity by peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients.
    Bose A; Chakraborty T; Chakraborty K; Pal S; Baral R
    Cancer Immun; 2008 Jun; 8():10. PubMed ID: 18547033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of T helper type 17 and regulatory T cell activity in tumour immunology of bladder carcinoma.
    Chi LJ; Lu HT; Li GL; Wang XM; Su Y; Xu WH; Shen BZ
    Clin Exp Immunol; 2010 Sep; 161(3):480-9. PubMed ID: 20646003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-12 delivered by biodegradable microspheres promotes the antitumor activity of human peripheral blood lymphocytes in a human head and neck tumor xenograft/SCID mouse model.
    Kuriakose MA; Chen FA; Egilmez NK; Jong YS; Mathiowitz E; DeLacure MD; Hicks WL; Loree TL; Bankert RB
    Head Neck; 2000 Jan; 22(1):57-63. PubMed ID: 10585606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma.
    Nguyen N; Bellile E; Thomas D; McHugh J; Rozek L; Virani S; Peterson L; Carey TE; Walline H; Moyer J; Spector M; Perim D; Prince M; McLean S; Bradford CR; Taylor JM; Wolf GT;
    Head Neck; 2016 Jul; 38(7):1074-84. PubMed ID: 26879675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.